<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl2">
 <label>Table 2</label>
 <caption>
  <p>Molecular targets of hispolon in various cancer types.</p>
 </caption>
 <alt-text id="alttext0055">Table 2</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Cancer type</th>
    <th>Cell line</th>
    <th>No. of cells/well</th>
    <th>Treatment time</th>
    <th>IC
     <sub>50</sub>
    </th>
    <th>Molecular targets</th>
    <th>Cell cycle arrest</th>
    <th>References</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Glioblastoma</td>
    <td align="left">U87MG</td>
    <td align="left">1 × 10
     <sup>4</sup>
    </td>
    <td align="left">24, 48, 72 h</td>
    <td align="left">–</td>
    <td align="left">Cyclin D4↓, p2↑, p53↑, CDK4↓, p-ERK 1↓1</td>
    <td align="left">G2/M</td>
    <td align="left">
     <xref rid="bib4" ref-type="bibr">Arcella et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Cervical</td>
    <td align="left">HeLa, SiHa</td>
    <td align="left">7 × 10
     <sup>4</sup>
    </td>
    <td align="left">24 h</td>
    <td align="left">–</td>
    <td align="left">p-AKT↓, ERK 
     <sup>Act</sup>, LC3- II↑, MMP-2↓, MMP-9↓
    </td>
    <td align="left">–</td>
    <td align="left">
     <xref rid="bib39" ref-type="bibr">Hsin et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Breast</td>
    <td align="left">MCF-7, T47D, MDA-MB-231</td>
    <td align="left">5 × 10
     <sup>3</sup>, 5 × 10
     <sup>4</sup>
    </td>
    <td align="left">24 h</td>
    <td align="left">70 Mm</td>
    <td align="left">ERα↓, PARP↑, Bcl-2↓, E-cadherin↓, MMP-9↓, p-IκBα┴, p- NF-κB↓</td>
    <td align="left">–</td>
    <td align="left">(
     <xref rid="bib45" ref-type="bibr">Jang et al., 2015</xref>; 
     <xref rid="bib80" ref-type="bibr">Sun et al., 2015</xref>; 
     <xref rid="bib98" ref-type="bibr">Zhao et al., 2016</xref>; 
     <xref rid="bib86" ref-type="bibr">Wang et al., 2017</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Naso-pharyngeal</td>
    <td align="left">HONE-1, NPC-39, NPC-BM, NPC-039</td>
    <td align="left">5 × 10
     <sup>4</sup>
    </td>
    <td align="left">–</td>
    <td align="left">–</td>
    <td align="left">p-Akt┴, uPA┴, MMP-2↓, MMP-9↓, caspase-3 
     <sup>Act</sup>, caspase-8 
     <sup>Act</sup>, caspase-9 
     <sup>Act</sup>
    </td>
    <td align="left">–</td>
    <td align="left">(
     <xref rid="bib37" ref-type="bibr">Hsieh et al., 2014</xref>; 
     <xref rid="bib33" ref-type="bibr">Ho et al., 2017</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Lung</td>
    <td align="left">A549, H661</td>
    <td align="left">1 × 10
     <sup>4</sup>
    </td>
    <td align="left">24, 48, 72 h</td>
    <td align="left">35.9 ± 6.9, 28.8 ± 3.1, 8.1 ± 2.3 μM</td>
    <td align="left">Cyclin D1↓, CDK2↓, CDK4↓, cyclin E↓, CDK6↓, p27↑, p21↑</td>
    <td align="left">G0/G1</td>
    <td align="left">
     <xref rid="bib89" ref-type="bibr">Wu et al. (2014)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Prostate</td>
    <td align="left">DU145, LNCaP, PC3</td>
    <td align="left">–</td>
    <td align="left">–</td>
    <td align="left">31 μM, 30 μM, 28 μM</td>
    <td align="left">cyclin B1↓, cyclin D1↓, CDK4↓, p21↑, p-STAT3↓</td>
    <td align="left">S phase</td>
    <td align="left">
     <xref rid="bib60" ref-type="bibr">Masood et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Leukemia</td>
    <td align="left">NB4, OCI-AML3</td>
    <td align="left">1 × 10
     <sup>4</sup>
    </td>
    <td align="left">12, 24, 48 h</td>
    <td align="left">7.98, 2.26 μg/mL</td>
    <td align="left">Fas↑, FasL↑, Bcl-2↓, PARP↑, caspase-9↑, Bax↑, caspase-3↑ p53↑, p27↑, p21↑, CDK2↓, CDK4↓, cyclin E↓, cyclin D1↓</td>
    <td align="left">G0/G1</td>
    <td align="left">
     <xref rid="bib15" ref-type="bibr">Chen et al. (2013)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Acute myeloid Leukemia</td>
    <td align="left">MOLM-13, HL-60, MV4-11, U937, THP-1</td>
    <td align="left">1 × 10
     <sup>5</sup>
    </td>
    <td align="left">24 h</td>
    <td align="left">25 Μm</td>
    <td align="left">Caspase-3 
     <sup>Act</sup>, caspase-8 
     <sup>Act</sup>, caspase-9 
     <sup>Act</sup>, PARP↑
    </td>
    <td align="left">–</td>
    <td align="left">
     <xref rid="bib36" ref-type="bibr">Hsiao et al. (2013)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Gastric</td>
    <td align="left">SGC-7901, MGC-803, MKN-45</td>
    <td/>
    <td align="left">24, 48,72 h</td>
    <td align="left">15.6, 11.4, 7.5 μg/mL</td>
    <td align="left">Caspase-3 
     <sup>Act</sup>, caspase-9 
     <sup>Act</sup>, Bax↑, Bak↑, Bcl-2↓, Bcl-xL↓, ROS↑
    </td>
    <td align="left">–</td>
    <td align="left">
     <xref rid="bib14" ref-type="bibr">Chen et al. (2008)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Bladder</td>
    <td align="left">T24, J82</td>
    <td align="left">2 × 10
     <sup>4</sup>
    </td>
    <td align="left">–</td>
    <td align="left">10 μg/mL,
     <break/>40 μg/mL
    </td>
    <td align="left">p-21↑</td>
    <td align="left">G2/M</td>
    <td align="left">
     <xref rid="bib58" ref-type="bibr">Lu et al. (2009)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Hepatocellular</td>
    <td align="left">Hep3B, SK-Hep1</td>
    <td align="left">2 × 10
     <sup>5</sup>
    </td>
    <td align="left">24 h</td>
    <td align="left">–</td>
    <td align="left">cyclin A↓, cyclin E↓, CDK2↓, JNK 
     <sup>Act</sup>, p38 MAPK 
     <sup>Act</sup> MMP-2↓, MMP-9↓, uPA↓, FAK↓
    </td>
    <td align="left">S phase</td>
    <td align="left">(
     <xref rid="bib40" ref-type="bibr">Huang et al., 2010</xref>, 
     <xref rid="bib42" ref-type="bibr">2011b</xref>
     <xref rid="bib40" ref-type="bibr">bib_Huang_et_al_2010</xref>
     <xref rid="bib42" ref-type="bibr">bib_Huang_et_al_2011b</xref>)
    </td>
   </tr>
   <tr>
    <td align="left">Epithelial</td>
    <td/>
    <td align="left">1 × 10
     <sup>4</sup>
    </td>
    <td align="left">24 h</td>
    <td align="left">–</td>
    <td align="left">Snail↓, Twist↓</td>
    <td align="left">–</td>
    <td align="left">
     <xref rid="bib35" ref-type="bibr">Hong et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Renal</td>
    <td align="left">TCMK-1</td>
    <td/>
    <td/>
    <td/>
    <td align="left">TRAIL↑</td>
    <td align="left">–</td>
    <td align="left">
     <xref rid="bib96" ref-type="bibr">Yun et al. (2019)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">Human Epidermoid</td>
    <td align="left">KB cells</td>
    <td align="left">5 × 10
     <sup>3</sup>
    </td>
    <td align="left">–</td>
    <td align="left">4.62 ± 0.16 μg/mL</td>
    <td align="left">Caspase-3 
     <sup>Act</sup>
    </td>
    <td align="left">–</td>
    <td align="left">
     <xref rid="bib13" ref-type="bibr">Chen et al. (2006)</xref>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Cyclin dependent kinase 4 (CDK4); Protein kinase B (Akt); light chain 3 (LC3); matrix metalloproteinase (MMP); poly-ADP ribose polymerase (PARP); Fas ligand (FasL); Mitogen activated protein kinase (MAPK); Reactive oxygen species (ROS); Zinc finger protein SNAI1 (Snail); TNF-related apoptosis-inducing ligand (TRAIL); Focal adhesion kinase (FAK).</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
